The P2X7 receptor: a key determinant of cellular metabolic energetics in cancer progression - AIRC IG 18581

COST Action BM1406 "Ion Channels and Immune Response toward a global understanding of immune cell physiology and for new therapeutic approaches (IONCHAN-IMMUNRESPON)"

Ricerca Finalizzata Ministero della Salute/Finalized Research Ministry of Health (RF-2011-02348435, 480 000 euro) Titolo/Title Investigation of the role of extracellular ATP and the P2X7 receptor in the modulation of immunosuppression within tumour microenvironment.

AIRC IG 13025: The P2X7 receptor is a key switch of cancer cell glycolytic metabolism

I recettori purinergici P2 e le ectonucleotidasi: nuovi bersagli per lo sviluppo di farmaci anti-tumorali/P2 purinergic receptors and ectonucleotidases: novel targets for anti-cancer drugs (FIRB Accordi di programma n. RBAP11FXBC)

Purinergic Signalling, Abstracts 8th International Symposium on Adenosine and Adenine Nucleotides